Tuesday, 12 June 2018

LUPIN LTD surges by 5%; BSE HEALTHCARE Index Up 2.1%

LUPIN LTD share price has Zoomed 5% and is presently trading at Rs 850.
Meanwhile, the BSE HEALTHCARE Index is at 13,777 (Up 2.1%).
Among the top Gainers in the BSE HEALTHCARE Index today is LUPIN LTD (up 5.23%).
SHILPA MEDICARE (down 0.05%) and LAURUS LABS LTD (down 0.09%) are among the top losers today.
Over the last one year, LUPIN LTD has moved down from Rs 1,157 to Rs 850, registering a loss of Rs 307 (down 26.57%)
On the other hand, the BSE HEALTHCARE has moved down from 14,264 to 13,777, loss of 487 points (down 3.43%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were BIOCON LTD (up 77.65%), DIVIS LABORATORIES (up 64.17%) and PFIZER (up 56.66%).

What About the Benchmark Indices?

The BSE Sensex is at 35,726 (up 0.66%).
The top gainers among the BSE Sensex stocks today are DR. REDDYS LAB (up 4.86%), SBI (up 2.27%) and INDUSIND BANK (up 1.49%). Other gainers include SUN PHARMA (up 1.40%) and TCS (up 1.39%). The most traded stocks in the BSE Sensex are ADANI PORTS & SEZ and SBI.
In the meantime, NSE Nifty is at 10,856 (up 0.60%). LUPIN LTD (up 5.51%) is among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 31,096 to 35,726, registering a gain of 4,630 points (up 14.86%).

LUPIN LTD Financial Update...

LUPIN LTD net profit declined 453.9% YoY to Rs 8 billion for the quarter ended March 2018, compared to a loss of Rs 2 billion a year ago. Net Sales rose 101.5% to Rs 40.3 billion during the period as against Rs 39.8 billion in January-March 2017.
For the year ended March 2017, LUPIN LTD reported 12.9% increase in net profit to Rs 25.6 billion compared to net profit of Rs 22.6 billion during FY16.
Revenue of the company grew 22.7% to Rs 175 billion during FY17.
The current Price to earnings ratio of LUPIN LTD, based on rolling 12 month earnings, stands at 152.9x.
This article was originally published in English at www.equitymaster.com
Read the complete Indian stock market update. For the terms of use, go here.

No comments:

Post a Comment